Comparative analysis of molecular signatures suggests the use of gabapentin for the management of endometriosis-associated pain
B. Bellessort, A. Bachelot, V. Grouthier, C. De Lombares, N. Narboux-Neme, P. Garagnani, C. Pirazzini, S. Astigiano, L. Mastracci, A. Fontaine, G. Alfama, E. Duvernois-Berthet, G. Levi
The paper identifies CACNA2D1, CACNA2D2, and CACNA2D3 as potential targets for gabapentin in treating endometriosis-associated pain through comparative gene expression analysis.
bioRxiv · Jan 22, 2018Pharmacology & Toxicology